FDA Approves Meningitis Vaccine for Princeton Outbreak

Bexsero will be available to students on campus

  • Share
  • Read Later

Federal health officials have approved a meningitis vaccine previously unavailable in the United States to contain an outbreak at Princeton University.

Bexsero, a vaccine approved in Australia and Europe, fights off strain B of the disease. Several students at Princeton have been diagnosed with the strain, which is typically uncommon in the U.S., Barbara Reynolds, a spokeswoman for the Centers for Disease Control and Prevention, told Reuters.

The Food and Drug Administration agreed to expedite Bexsero’s approval in order to offer it as an optional vaccine to students on campus. Last week school officials reported a seventh case of the meningitis outbreak, which began in March.

University trustees convened to discuss the outbreak this weekend, but it is unclear when the vaccine will be available.



Our hearts and support go out to those affected by the terrible effects of meningitis. The Meningitis Foundation of America offers extensive information regarding diagnosis, immunization, recovery and the after effects of meningitis. MFA survives primarily by donations. For the past 16 years, we have assisted people through support groups, resources and advocacy in efforts to help those affected with meningitis overcome and those around them understand the journey ahead. We promote prevention and safety measure in at risk communities and help explain the short term, long term effects and recovery treatments of meningitis to the media and public at large.Meningitis is a dangerous & often times fatal infection that can lead to serious life-long physical problems and even death. We are here to provide emotional support to those who need it; please feel free to reach out to us at www.musa.org and customersupport@musa.org

Daisi Pollard Sepúlveda-Low

National President

Meningitis Foundation of America, Inc.

World Meningitis Day 24 April